FDA Inspection
Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API).Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API). – FDA Inspection, Aug 23, 2019
Record Details
This FDA Inspection record concerns Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API)., with an inspection on August 23, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 23, 2019
- Product Type
- Drugs
View Company Profile
ID · ca2399ad-099c-4dd6-8645-d5e4d53d28df
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1101264
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API).
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 20, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 1, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API).
- FDA Inspection 1214801 - 2023-07-20
- FDA Inspection 893334 - 2014-08-01
- FDA Inspection 738535 - 2011-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.